8.7% Dividend Yield: Is KP Tissue Stock a Good Buy?

This top TSX stock is certainly one to consider for that dividend yield, but is that dividend safe given the numbers?

| More on:
calculate and analyze stock

Image source: Getty Images

KP Tissue (TSX:KPT) might catch the eye of dividend investors with its impressive 8.7% dividend yield. Yet there’s more to the story than just that high number. To understand whether KPT is a good buy, let’s explore its recent earnings, past performance, and future outlook, as well as the risks and rewards of such an investment.

The numbers

In its third-quarter 2024 earnings report, KP Tissue showed solid growth, with revenue increasing by 10.1% year over year to $521.1 million. This was largely driven by higher sales volumes and favourable pricing initiatives, reflecting the company’s ability to maintain a strong foothold in its market. However, the company’s adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) took a hit. A key measure of profitability, it decreased by $6.7 million year over year, bringing the margin down to 12.6% from 15.3% the prior year. Rising costs, particularly for pulp and freight, were significant contributors to this squeeze in margins.

On the income side, KP Tissue reported a net income of $18 million for the third quarter (Q3) of 2024, an increase of $5.1 million compared to the same quarter in 2023. This improvement is commendable. Yet the company’s financial health remains a mixed bag. Its cash position fell by $16 million in Q3, and net debt increased by $4.5 million. With a leverage ratio rising to 4.1 times EBITDA, the TSX stock is operating with heightened financial risk. While KP Tissue has taken steps to improve liquidity, investors should remain mindful of its rising debt levels.

Market sentiment around KP Tissue is cautious, reflected in its stock performance and analyst ratings. The TSX stock has traded within a 52-week range of $7.99 to $9.41, indicating limited volatility with a beta of 0.37. While this can be comforting for risk-averse investors, the broader picture reveals concerns about sustainability. The TSX stock’s dividend payout ratio of 120% means it is paying out more in dividends than it earns. This raises red flags about the long-term feasibility of its high dividend yield unless earnings significantly improve.

Considerations

Looking at past performance, KP Tissue’s five-year average dividend yield of 7.18% shows consistency in offering income to shareholders. Yet, its recent quarterly earnings drop at 40.8% year-over-year raises questions about its ability to sustain such payouts. The TSX stock’s return on equity (ROE) of 8.58% is modest but not extraordinary. And it will need stronger profitability to bolster investor confidence.

The TSX stock’s strategic initiatives could provide some optimism. KP Tissue is moving forward with plans to expand its production capabilities, including a new tissue plant under consideration. This could enhance market share and operational efficiency, potentially driving higher revenues and profitability. However, the tissue market remains competitive, and rising input costs continue to present challenges. To succeed, the TSX stock will need to navigate these obstacles effectively while executing its growth strategies.

The stock’s current price of $8.28 as of writing is near the lower end of its 52-week range, suggesting limited upside unless the TSX stock delivers strong performance improvements. However, its defensive nature of low volatility and steady dividend payments might appeal to income-focused investors who are willing to accept some risk in exchange for a high yield.

Bottom line

For long-term investors, KP Tissue presents both opportunities and challenges. The high dividend yield is undeniably appealing, especially in today’s low-yield environment. Yet the underlying financials suggest caution. Investors should assess whether they believe in the company’s ability to overcome its margin pressures and debt challenges while maintaining its attractive payouts.

Ultimately, KP Tissue’s dividend yield might look like a golden opportunity, but it comes with strings attached. The TSX stock faces profitability and sustainability hurdles, making it a potentially risky choice for conservative investors. Those seeking income might consider diversifying their portfolios with more stable dividend payers. Those willing to take a chance on KP Tissue should monitor its earnings growth and operational developments closely.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Dividend Stocks

woman analyze data
Dividend Stocks

Secure Dividends: How to Turn $10,000 Into Reliable Passive Income

Earn a secure dividend income of over $150 every quarter by investing in these reliable Canadian dividend stocks.

Read more »

top TSX stocks to buy
Dividend Stocks

Buy the Dip: This Top TSX Dividend Stock Just Became a Must-Own

This retail dividend stock is a Canadian legend, allowing investors to get in on some serious action with a strong…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

How to Build a $1 Million TFSA Starting With Just $10,000

Two established, high-yield dividend stocks can help turn a small seed capital into a million-dollar TFSA.

Read more »

money cash dividends
Dividend Stocks

Here’s How Many Shares of FIE You Should Own to Get $500 in Monthly Dividends

This monthly-paying dividend ETF is simple to understand.

Read more »

sale discount best price
Dividend Stocks

Is This Correction Your Chance? Top 5 Canadian Dividend Stocks on Sale

For value, income, and long-term growth, check out these top five dividend stocks.

Read more »

Stethoscope with dollar shaped cord
Dividend Stocks

Canadian Investors: Buy WELL Health Stock Right Now

WELL Health (TSX:WELL) stock might be on the downturn right now, but a bargain for value-seeking investors for their self-directed…

Read more »

A worker gives a business presentation.
Dividend Stocks

3 No-Brainer Canadian Stocks to Buy Under $70

Investing in stocks need not require you to burn a hole in your pocket. You can invest $70 to $100…

Read more »

View of high rise corporate buildings in the financial district of Toronto, Canada
Dividend Stocks

Canadian Real Estate Stocks Plummet: Is it Time to Sell or Buy?

Real estate stocks have a lot going for the, especially dividends. But are they all a buy or due to…

Read more »